US Stock MarketDetailed Quotes
SHTDY SINOPHARM GROUP CO
- 13.531
- +0.226+1.70%
15min DelayClose Nov 29 13:00 ET
8.45BMarket Cap7.08P/E (TTM)
13.531High13.045Low6.66KVolume13.045Open13.305Pre Close87.63KTurnover0.00%Turnover Ratio6.76P/E (Static)624.13MShares15.58452wk High0.81P/B8.45BFloat Cap10.13052wk Low0.61Dividend TTM624.13MShs Float23.273Historical High4.53%Div YieldTTM3.65%Amplitude7.281Historical Low13.151Avg Price1Lot Size
SINOPHARM GROUP CO Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Net income from continuing operations | ---- | ---- | 5.11%19.51B | 9.18%18.56B | 9.01%17B | 13.36%15.6B | 12.71%13.76B | 8.74%12.21B | 25.79%11.23B | 19.49%8.92B |
| Other non cash items | ---- | ---- | -1.14%-98.92M | -102.74%-97.81M | 10.02%3.57B | -1.64%3.25B | 23.37%3.3B | 2.11%2.67B | 33.72%2.62B | -3.86%1.96B |
| Change In working capital | ---- | ---- | -86.36%-3.86B | 82.86%-2.07B | -38.78%-12.1B | -1,979.34%-8.72B | 104.35%463.99M | -26.08%-10.67B | -6,525.54%-8.46B | -102.66%-127.68M |
| -Change in receivables | ---- | ---- | -2,191.13%-14.85B | 102.66%710.12M | -18.05%-26.72B | -74.55%-22.63B | 46.85%-12.97B | -266.57%-24.39B | -37.14%-6.65B | -321.27%-4.85B |
| -Change in inventory | ---- | ---- | 104.79%455.56M | -118.72%-9.5B | -18.23%-4.35B | 39.95%-3.68B | -24.25%-6.12B | -240.09%-4.93B | 59.31%-1.45B | -94.37%-3.56B |
| -Change in prepaid assets | ---- | ---- | 165.10%4.89B | -6,060.39%-7.5B | 117.91%125.9M | -1,254.34%-702.9M | 106.27%60.89M | 88.83%-971.7M | -112.89%-8.7B | -402.75%-4.09B |
| -Change in other current assets | ---- | ---- | -170.37%-3.04B | 441.14%4.31B | -158.76%-1.26B | 304.64%2.15B | ---1.05B | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | ---- | ---- | -18.08%17.17B | 125.22%20.96B | -16.55%9.31B | -40.59%11.15B | 413.91%18.78B | 13.87%3.65B | -65.34%3.21B | -30.97%9.26B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Net PPE purchase and sale | ---355.25M | ---428.24M | 34.37%-1.35B | -6.27%-2.05B | -13.70%-1.93B | 23.32%-1.7B | 27.15%-2.21B | -54.67%-3.04B | -128.73%-1.97B | 9.85%-859.25M |
| Net intangibles purchase and sale | ---- | ---- | -71.66%-324.01M | -23.31%-188.75M | 3.07%-153.06M | -2.08%-157.91M | 3.16%-154.7M | -7.10%-159.75M | 1.94%-149.16M | 45.02%-152.1M |
| Net business purchase and sale | ---97.34M | ---97.04M | 90.54%-31.86M | 31.05%-336.71M | 79.88%-488.36M | -96.65%-2.43B | -318.27%-1.23B | 67.13%-295.12M | -114.25%-897.79M | -16.31%-419.04M |
| Net investment purchase and sale | --422.09M | --67.77M | -78.49%23.99M | -50.13%111.53M | 199.55%223.63M | -275.01%-224.65M | 87.44%-59.9M | -2.71%-476.93M | -5,858.28%-464.33M | -107.21%-7.79M |
| Net other investing changes | --1.02B | --713.63M | 105.83%102.91M | -415.16%-1.76B | -68.68%559.74M | 150.16%1.79B | -46.69%-3.56B | -9,928.17%-2.43B | 106.87%24.72M | -5.18%-359.68M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --977.04M | --256.12M | 73.69%-944.54M | -183.33%-3.59B | 42.48%-1.27B | 67.59%-2.2B | -15.04%-6.8B | -86.97%-5.91B | -96.68%-3.16B | 2.24%-1.61B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Net issuance payments of debt | --2.51B | --15.57B | -47.29%2.5B | 199.17%4.75B | -159.58%-4.79B | 286.84%8.03B | -130.10%-4.3B | 84.26%14.28B | 233.32%7.75B | 162.96%2.33B |
| Net common stock issuance | ---- | --59.88M | ---- | ---- | ---- | 7,078.98%3.6B | 1,670.28%50.15M | 102.83%2.83M | ---99.98M | --0 |
| Cash dividends paid | ---- | ---1.11B | -9.33%-2.56B | -8.70%-2.34B | -15.45%-2.15B | -6.38%-1.87B | -11.18%-1.75B | -13.99%-1.58B | -21.94%-1.38B | -32.26%-1.13B |
| Net other financing activities | ---1.42B | --7.64B | -98.42%2.72M | -38.79%171.93M | -2.27%280.88M | -72.96%287.4M | -60.71%1.06B | 93.49%2.7B | 287.58%1.4B | -631.29%-745.25M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---1.54B | --22.15B | -34.26%-7.64B | 61.25%-5.69B | -825.27%-14.69B | 115.48%2.03B | -226.81%-13.08B | 159.33%10.32B | 296.30%3.98B | 71.69%-2.03B |
| Net cash flow | ||||||||||
| Beginning cash position | --43.33B | --63.81B | 26.86%55.22B | -13.25%43.53B | 28.03%50.18B | -2.75%39.19B | 24.99%40.3B | 14.31%32.24B | 41.26%28.21B | 30.45%19.97B |
| Current changes in cash | ---7.29B | ---25.07B | -26.51%8.58B | 275.60%11.68B | -160.59%-6.65B | 1,094.87%10.98B | -113.68%-1.1B | 100.22%8.06B | -28.39%4.03B | 22.03%5.62B |
| Effect of exchange rate changes | ---8.41M | --651.16K | -79.25%2.39M | 277.81%11.51M | -64.54%3.05M | 339.89%8.59M | 44.42%-3.58M | -181.68%-6.45M | 144.23%7.89M | -135.11%-17.84M |
| End cash Position | --36.03B | --38.74B | 15.55%63.81B | 26.86%55.22B | -13.25%43.53B | 28.03%50.18B | -2.75%39.19B | 24.99%40.3B | 26.07%32.24B | 28.08%25.57B |
| Free cash flow | ---6.81B | ---47.95B | -20.00%14.84B | 162.98%18.55B | -22.22%7.05B | -44.13%9.07B | 6,401.21%16.23B | -73.39%249.62M | -88.12%938.2M | -34.84%7.89B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data